查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1865451

全球固態和液體製藥生產自動化市場預測至2032年：按劑型、包裝類型、技術、應用、最終用戶和地區分類的全球分析

Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Forecasts to 2032 - Global Analysis By Dosage Form, Packaging Type, Technology, Application, End User and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

據 Stratistics MRC 稱，2025 年全球固態和液體劑型製藥生產過程自動化市場規模預計將達到 70 億美元，到 2032 年將達到 150 億美元，預測期內複合年成長率為 11.5%。

在製藥生產中，自動化是指利用控制系統運作固態（片劑、膠囊）和液體（糖漿、注射）生產設備，最大限度地減少人為干預。這包括分裝、混合、製粒、壓片、填充和包裝等流程。自動化能夠提高生產精度和效率，並加強對嚴格法規的遵守。透過確保產品品質的穩定性、降低污染風險以及提高批次可追溯性，自動化對於擴大生產規模和維持良好生產規範 (GMP) 至關重要。

根據 Springer 出版的《治療創新與監管科學》雜誌報道，人工智慧 (AI) 正在透過實現數據驅動的最佳化來改變液體藥物製劑，提高藥物發現、製劑設計和生產的效率，並減少對試驗法的依賴。

對生產效率的需求不斷成長

對提高生產效率的日益重視正推動固態和液體製劑製藥生產中自動化技術的應用。減少人工干預、提高精度和最佳化生產效率的需求日益成長，促使製造商投資先進的自動化系統。自動化解決方案能夠簡化操作、縮短週期時間並確保品質穩定，尤其對於複雜劑型更是如此。此外，機器人和人工智慧驅動的控制系統的整合提高了製程可靠性，確保符合監管標準並實現製藥生產的擴充性。

大筆初始投資

儘管自動化具有許多優勢，但高昂的初始投資仍是製藥製劑生產自動化廣泛應用的主要障礙。機器人、視覺檢測和數位監控技術的整合需要大量資金，尤其對於中小企業而言更是如此。此外，客製化和驗證成本進一步加重了財務負擔。嚴格的合規要求和複雜的維護流程也促使許多公司推遲採用自動化技術。這導致投資回收期延長，並限制了該技術在新興製藥生產環境中的快速普及。

個性化醫療包裝的發展

個人化醫療的興起為製藥生產創造了盈利的自動化機會。隨著定製劑型和患者特異性治療方法的日益普及，自動化包裝和給藥系統能夠確保精確度和靈活性。先進的機器人技術和自適應控制技術實現了批次級客製化和即時調整。在以人為本的給藥需求驅動下，自動化有助於減少錯誤、增強可追溯性並簡化小批量生產。因此，製藥公司正在採用數位自動化來支持其基於個人化和精準性的藥物包裝流程的擴充性。

供應鏈中斷影響自動化

全球供應鏈中斷對自動化主導的製藥生產構成重大威脅。半導體供應中斷、設備物流中斷和零件短缺會阻礙系統整合和試運行。此外，對專業供應商的自動化組件依賴會加劇地緣政治緊張局勢下的脆弱性。材料成本波動和安裝延誤會增加生產連續性風險。因此，企業越來越重視在地化籌資策略和建立具有韌性的供應商網路，以減少自動化停機時間並維持製藥生產線的運作可靠性。

新冠疫情的影響：

由於對不間斷生產的需求激增，新冠肺炎疫情加速了固態和液體製劑生產中自動化技術的應用。勞動力短缺和保持社交距離的規定促使企業轉向機器人搬運和自動化檢測系統。此外，遠端監控和數位雙胞胎技術也為預測性維護和品管提供了支援。然而，疫情初期的封鎖措施延緩了設備的採購和安裝。隨著時間的推移，這場危機更加凸顯了自動化的戰略必要性，提升了生產的靈活性，並增強了整個製藥生產流程的韌性。

預計在預測期內，固態製劑自動化細分市場將佔據最大的市場佔有率。

預計在預測期內，固態製劑自動化領域將佔據最大的市場佔有率，這主要得益於其在片劑壓制、包衣和包裝流程中的廣泛應用。製造商對大規模片劑生產中精度和可重複性的重視，推動了自動化技術的應用。在對一致性和合規性需求的驅動下，自動化系統提高了生產效率和品管水準。此外，該領域還受益於對機器人配料、自動填充和檢測單元投資的增加，這些設備有助於減少操作變異性。

預計在預測期內，初級包裝自動化領域將實現最高的複合年成長率。

由於對產品安全和污染預防的需求不斷成長，預計在預測期內，初級包裝自動化領域將實現最高成長率。在嚴格的監管要求推動下，自動化初級包裝系統提高了密封精度並最大限度地減少了人為接觸。此外，固態和液體劑型產品向泡殼、小袋包裝和管瓶包裝的轉變也加速了這一領域的應用。機器視覺和人工智慧的整合，確保了標籤的準確性和可追溯性，進一步推動了該領域的擴張。

佔比最大的地區：

亞太地區預計將在預測期內保持最大的市場佔有率，這主要得益於中國、印度和韓國製藥業的快速擴張。政府鼓勵工業自動化和投資先進生產設施的激勵措施正在推動成長。此外，學名藥產量的增加和契約製造活動的活性化也促進了自動化整合。該地區不斷成長的熟練勞動力和經濟高效的實施環境進一步鞏固了其在固態和液體製劑生產自動化應用方面的領先地位。

複合年成長率最高的地區：

在預測期內，由於北美地區大力推進數位轉型並率先採用新技術，該地區有望實現最高的複合年成長率。該地區完善的法規結構有利於透過自動化進行流程驗證。此外，對智慧工廠和數據驅動型製造的投資不斷增加，也提升了生產的靈活性。在個人化醫療日益受到重視以及美國食品藥物管理局（FDA）嚴格監管的推動下，美國和加拿大各地的藥品生產設施的自動化應用持續激增。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，提供主要國家的市場估算和預測以及複合年成長率（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要參與者的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球固態和液體製藥生產自動化市場（按劑型分類）

  • 固態劑量自動化
    • 片劑生產
    • 膠囊填充和密封系統
    • 製粒、混合和壓縮控制
  • 液體劑型自動化
    • 糖漿和懸浮液的生產
    • 無菌填充和滅菌系統
    • 液體混合和均質化
  • 半固態製劑自動化
    • 軟膏和乳霜的生產
    • 凝膠和糊狀物混合系統
    • 管材填充和密封

6. 全球固態和液體製藥生產自動化市場（按包裝類型分類）

  • 初級包裝自動化
    • 泡殼包裝機
    • 瓶裝填充和封蓋系統
    • 條狀包裝設備
    • 管瓶和安瓿包裝
    • 小袋和包裝袋填充系統
  • 二級包裝自動化
    • 紙箱和包裝箱系統
    • 捆紮、包裝、收縮包裝
    • 序列化和聚合系統
    • 碼垛、卸垛和貼標機器人
  • 三級包裝自動化
    • 用於倉庫作業的自動導引車 (AGV)
    • 散裝搬運和運輸貨櫃系統

7. 全球固態和液體製藥生產自動化市場（按技術分類）

  • 機器人和取放系統
  • 視覺檢測系統
  • 標籤和序列化系統
  • 輸送機和自動化物料搬運
  • 吹塑-填充-密封（BFS）技術
  • 成型-填充-密封（FFS）系統

8. 全球固態和液體製藥生產自動化市場（按應用領域分類）

  • 藥物發現與開發
  • 臨床試驗材料生產
  • 商業化生產與加工
    • 活性藥物成分（API）生產
    • 配方和組成
  • 品管和法規遵從
  • 物流和庫存管理

9. 全球固態和液體製藥生產自動化市場（按最終用戶分類）

  • 製藥公司
  • 生技公司
  • 合約研發生產組織（CDMO/CMO）
  • 研究和學術機構
  • 包裝和設備製造商

10. 全球固態和液體製藥生產自動化市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第12章 企業概況

  • Siemens Healthineers
  • Rockwell Automation
  • Bosch Packaging Technology
  • Syntegon Technology
  • Korber Pharma
  • Becton Dickinson（BD）
  • IMA Group
  • Marchesini Group
  • OPTIMA Packaging Group
  • Uhlmann Pac-Systeme
  • Omnicell Inc.
  • ARxIUM
  • Yuyama Co., Ltd.
  • Mitsubishi Electric
  • Honeywell Process Solutions
  • GEA Group
  • Thermo Fisher Scientific
  • Schneider Electric
Product Code: SMRC32165

According to Stratistics MRC, the Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market is accounted for $7.0 billion in 2025 and is expected to reach $15.0 billion by 2032 growing at a CAGR of 11.5% during the forecast period. Automation in pharmaceutical manufacturing involves using control systems to operate equipment for producing solid (tablets, capsules) and liquid (syrups, injections) dosage forms with minimal human intervention. It encompasses processes like dispensing, mixing, granulation, compression, filling, and packaging. This enhances precision, efficiency, and compliance with stringent regulations. By ensuring consistent product quality, reducing contamination risks, and improving batch traceability, automation is vital for scaling up production and maintaining Good Manufacturing Practice (GMP).

According to Springer's Therapeutic Innovation & Regulatory Science journal, artificial intelligence is transforming liquid dosage formulation by enabling data-driven optimization. AI improves efficiency in drug discovery, formulation, and manufacturing, reducing reliance on trial-and-error methods

Market Dynamics:

Driver:

Rising demand for production efficiency

The increasing focus on improving production efficiency is propelling automation adoption in solid and liquid dosage pharmaceutical manufacturing. Fueled by the growing need to minimize manual intervention, enhance precision, and optimize throughput, manufacturers are investing in advanced automated systems. Automation solutions streamline operations, reduce cycle times, and ensure consistent quality, particularly in complex dosage formulations. Moreover, the integration of robotics and AI-driven control systems enhances process reliability, ensuring compliance with regulatory standards and scalability in pharmaceutical output.

Restraint:

High initial capital investment

Despite its benefits, high upfront investment acts as a key barrier to widespread automation deployment in pharmaceutical dosage manufacturing. The integration of robotics, vision inspection, and digital monitoring technologies requires significant capital, particularly for small and mid-sized firms. Additionally, customization and validation costs further elevate financial burdens. Spurred by stringent compliance requirements and maintenance complexities, many firms delay automation adoption. Consequently, the return on investment period extends, limiting faster technological penetration across developing pharmaceutical production environments.

Opportunity:

Growth in personalized medicine packaging

The emergence of personalized medicine is unlocking lucrative automation opportunities in pharmaceutical manufacturing. As customized dosage forms and patient-specific therapies gain traction, automated packaging and dosing systems ensure precision and flexibility. Advanced robotics and adaptive control technologies enable batch-level customization and real-time adjustments. Driven by the demand for individual-centric drug delivery, automation helps reduce errors, enhance traceability, and streamline small-batch production. Consequently, pharmaceutical players are adopting digital automation to support the scalability of personalized and precision-based drug packaging processes.

Threat:

Supply chain disruptions impact automation

Global supply chain disruptions pose a substantial threat to automation-driven pharmaceutical manufacturing. Interruptions in semiconductor availability, equipment logistics, and component shortages hinder system integration and commissioning. Moreover, dependency on specialized vendors for automation components amplifies vulnerability during geopolitical tensions. Spurred by fluctuating material costs and delayed installations, production continuity risks rise. Hence, companies increasingly focus on regionalized sourcing strategies and resilient supplier networks to mitigate automation downtime and maintain operational reliability in dosage manufacturing lines.

Covid-19 Impact:

The COVID-19 pandemic accelerated automation adoption across solid and liquid dosage manufacturing due to heightened demand for uninterrupted production. Fueled by labor shortages and social distancing norms, companies turned to robotic handling and automated inspection systems. Additionally, remote monitoring and digital twin technologies supported predictive maintenance and quality control. However, initial lockdowns delayed equipment procurement and installation. Over time, the crisis reinforced the strategic necessity for automation, transforming production agility and reinforcing resilience across pharmaceutical manufacturing workflows.

The solid dosage form automation segment is expected to be the largest during the forecast period

The solid dosage form automation segment is expected to account for the largest market share during the forecast period, propelled by its extensive application in tablet compression, coating, and packaging operations. Manufacturers are emphasizing precision and repeatability in large-scale tablet production, driving automation uptake. Fueled by demand for consistency and compliance, automated systems enhance throughput and quality control. Additionally, the segment benefits from increasing investments in robotic dispensing, automated filling, and inspection units that reduce operational variability.

The primary packaging automation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the primary packaging automation segment is predicted to witness the highest growth rate, influenced by rising requirements for product safety and contamination prevention. Driven by stringent regulatory mandates, automated primary packaging systems enhance sealing precision and minimize human contact. Furthermore, the growing shift toward blister, sachet, and vial packaging for both solid and liquid dosage forms accelerates adoption. Integration of machine vision and AI ensures labeling accuracy and traceability, boosting this segment's expansion trajectory.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by rapid pharmaceutical manufacturing expansion in China, India, and South Korea. Government incentives supporting industrial automation and investments in advanced production facilities bolster growth. Additionally, rising generics output and contract manufacturing activities enhance automation integration. The region's growing pool of skilled engineers and cost-effective deployment environments further strengthen its leadership in automated solid and liquid dosage manufacturing adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong digital transformation initiatives and early technology adoption among major pharmaceutical firms. The region's established regulatory framework encourages process validation through automation. Additionally, increasing investments in smart factories and data-driven manufacturing enhance production agility. Fueled by a growing focus on personalized medicine and stringent FDA compliance, automation uptake continues to surge across U.S. and Canadian dosage production facilities.

Key players in the market

Some of the key players in Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market include Siemens, Rockwell Automation, Bosch Packaging, Syntegon, Korber Pharma, Becton Dickinson, IMA Group, Marchesini, OPTIMA Packaging, Uhlmann Pac-Systeme, Omnicell, ARxIUM, Yuyama Co., Ltd., Mitsubishi Electric, Honeywell, GEA Group, Thermo Fisher, and Schneider Electric.

Key Developments:

In September 2025, Siemens and Merck extended their strategic partnership to accelerate digital transformation in pharmaceutical manufacturing. The collaboration aims to integrate Merck's SaaS products with Siemens' digital ecosystem, deploying AI tools for smarter, faster drug development using technology from Siemens' July 2025 Dotmatics acquisition.

In October 2025, Rockwell Automation launched the ControlLogix 5590 Controller, a next-generation platform designed for advanced industrial and pharmaceutical automation, featuring integrated safety and multidiscipline control for streamlined manufacturing.

In May 2025, Syntegon premiered its SynTiso line for automated liquid pharmaceutical filling, developed in direct collaboration with two major pharmaceutical partners, to enhance automation and yield while reducing operator intervention.

Dosage Forms Covered:

  • Solid Dosage Form Automation
  • Liquid Dosage Form Automation
  • Semisolid Dosage Form Automation

Packaging Types Covered:

  • Primary Packaging Automation
  • Secondary Packaging Automation
  • Tertiary Packaging Automation

Technologies Covered:

  • Robotics & Pick-and-Place Systems
  • Vision Inspection Systems
  • Labeling & Serialization Systems
  • Conveyors & Automated Material Handling
  • Blow-Fill-Seal (BFS) Technology
  • Form-Fill-Seal (FFS) Systems

Applications Covered:

  • Drug Discovery & Development
  • Clinical Trial Material Manufacturing
  • Commercial Production &Processing
  • Quality Control & Regulatory Compliance
  • Logistics & Inventory Management

End Users Covered:

  • Pharmaceutical Manufacturing Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • Research and Academic Institutions
  • Packaging & Equipment Manufacturers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Dosage Form

  • 5.1 Introduction
  • 5.2 Solid Dosage Form Automation
    • 5.2.1 Tablet Manufacturing
    • 5.2.2 Capsule Filling & Sealing Systems
    • 5.2.3 Granulation, Blending & Compression Control
  • 5.3 Liquid Dosage Form Automation
    • 5.3.1 Syrup & Suspension Production
    • 5.3.2 Aseptic Filling & Sterilization Systems
    • 5.3.3 Liquid Mixing & Homogenization
  • 5.4 Semisolid Dosage Form Automation
    • 5.4.1 Ointment & Cream Manufacturing
    • 5.4.2 Gel & Paste Mixing Systems
    • 5.4.3 Tube Filling & Sealing

6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Packaging Type

  • 6.1 Introduction
  • 6.2 Primary Packaging Automation
    • 6.2.1 Blister Packaging Machines
    • 6.2.2 Bottle Filling & Capping Systems
    • 6.2.3 Strip Packaging Equipment
    • 6.2.4 Vial and Ampoule Packaging
    • 6.2.5 Sachet and Pouch Filling Systems
  • 6.3 Secondary Packaging Automation
    • 6.3.1 Cartoning & Case Packing Systems
    • 6.3.2 Bundling, Wrapping, & Shrink Packaging
    • 6.3.3 Serialization & Aggregation Systems
    • 6.3.4 Palletizing, Depalletizing, & Labeling Robots
  • 6.4 Tertiary Packaging Automation
    • 6.4.1 Automated Guided Vehicles (AGVs) for Warehouse Handling
    • 6.4.2 Bulk Handling and Shipping Container Systems

7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Technology

  • 7.1 Introduction
  • 7.2 Robotics & Pick-and-Place Systems
  • 7.3 Vision Inspection Systems
  • 7.4 Labeling & Serialization Systems
  • 7.5 Conveyors & Automated Material Handling
  • 7.6 Blow-Fill-Seal (BFS) Technology
  • 7.7 Form-Fill-Seal (FFS) Systems

8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Discovery & Development
  • 8.3 Clinical Trial Material Manufacturing
  • 8.4 Commercial Production &Processing
    • 8.4.1 Active Pharmaceutical Ingredient (API) Manufacturing
    • 8.4.2 Formulation and Compounding
  • 8.5 Quality Control & Regulatory Compliance
  • 8.6 Logistics & Inventory Management

9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Manufacturing Companies
  • 9.3 Biotechnology Companies
  • 9.4 Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • 9.5 Research and Academic Institutions
  • 9.6 Packaging & Equipment Manufacturers

10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Siemens Healthineers
  • 12.2 Rockwell Automation
  • 12.3 Bosch Packaging Technology
  • 12.4 Syntegon Technology
  • 12.5 Korber Pharma
  • 12.6 Becton Dickinson (BD)
  • 12.7 IMA Group
  • 12.8 Marchesini Group
  • 12.9 OPTIMA Packaging Group
  • 12.10 Uhlmann Pac-Systeme
  • 12.11 Omnicell Inc.
  • 12.12 ARxIUM
  • 12.13 Yuyama Co., Ltd.
  • 12.14 Mitsubishi Electric
  • 12.15 Honeywell Process Solutions
  • 12.16 GEA Group
  • 12.17 Thermo Fisher Scientific
  • 12.18 Schneider Electric

List of Tables

  • Table 1 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Dosage Form (2024-2032) ($MN)
  • Table 3 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Solid Dosage Form Automation (2024-2032) ($MN)
  • Table 4 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tablet Manufacturing (2024-2032) ($MN)
  • Table 5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Capsule Filling & Sealing Systems (2024-2032) ($MN)
  • Table 6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Granulation, Blending & Compression Control (2024-2032) ($MN)
  • Table 7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Dosage Form Automation (2024-2032) ($MN)
  • Table 8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Syrup & Suspension Production (2024-2032) ($MN)
  • Table 9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Aseptic Filling & Sterilization Systems (2024-2032) ($MN)
  • Table 10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Mixing & Homogenization (2024-2032) ($MN)
  • Table 11 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Semisolid Dosage Form Automation (2024-2032) ($MN)
  • Table 12 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Ointment & Cream Manufacturing (2024-2032) ($MN)
  • Table 13 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Gel & Paste Mixing Systems (2024-2032) ($MN)
  • Table 14 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tube Filling & Sealing (2024-2032) ($MN)
  • Table 15 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging Type (2024-2032) ($MN)
  • Table 16 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Primary Packaging Automation (2024-2032) ($MN)
  • Table 17 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blister Packaging Machines (2024-2032) ($MN)
  • Table 18 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bottle Filling & Capping Systems (2024-2032) ($MN)
  • Table 19 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Strip Packaging Equipment (2024-2032) ($MN)
  • Table 20 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vial and Ampoule Packaging (2024-2032) ($MN)
  • Table 21 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Sachet and Pouch Filling Systems (2024-2032) ($MN)
  • Table 22 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Secondary Packaging Automation (2024-2032) ($MN)
  • Table 23 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Cartoning & Case Packing Systems (2024-2032) ($MN)
  • Table 24 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bundling, Wrapping, & Shrink Packaging (2024-2032) ($MN)
  • Table 25 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Serialization & Aggregation Systems (2024-2032) ($MN)
  • Table 26 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Palletizing, Depalletizing, & Labeling Robots (2024-2032) ($MN)
  • Table 27 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tertiary Packaging Automation (2024-2032) ($MN)
  • Table 28 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Automated Guided Vehicles (AGVs) for Warehouse Handling (2024-2032) ($MN)
  • Table 29 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bulk Handling and Shipping Container Systems (2024-2032) ($MN)
  • Table 30 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 31 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Robotics & Pick-and-Place Systems (2024-2032) ($MN)
  • Table 32 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vision Inspection Systems (2024-2032) ($MN)
  • Table 33 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Labeling & Serialization Systems (2024-2032) ($MN)
  • Table 34 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Conveyors & Automated Material Handling (2024-2032) ($MN)
  • Table 35 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blow-Fill-Seal (BFS) Technology (2024-2032) ($MN)
  • Table 36 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Form-Fill-Seal (FFS) Systems (2024-2032) ($MN)
  • Table 37 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Application (2024-2032) ($MN)
  • Table 38 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 39 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Clinical Trial Material Manufacturing (2024-2032) ($MN)
  • Table 40 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Commercial Production &Processing (2024-2032) ($MN)
  • Table 41 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2024-2032) ($MN)
  • Table 42 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Formulation and Compounding (2024-2032) ($MN)
  • Table 43 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Quality Control & Regulatory Compliance (2024-2032) ($MN)
  • Table 44 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Logistics & Inventory Management (2024-2032) ($MN)
  • Table 45 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By End User (2024-2032) ($MN)
  • Table 46 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Pharmaceutical Manufacturing Companies (2024-2032) ($MN)
  • Table 47 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
  • Table 48 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs/CMOs) (2024-2032) ($MN)
  • Table 49 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Research and Academic Institutions (2024-2032) ($MN)
  • Table 50 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging & Equipment Manufacturers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.